Literature DB >> 10672829

The esophageal Z-line appearance correlates to the prevalence of intestinal metaplasia.

B Wallner1, A Sylvan, R Stenling, K G Janunger.   

Abstract

BACKGROUND: Intestinal metaplasia at the gastroesophageal junction is associated with Barrett esophagus, gastric cardiac cancer, and gastritis. The aim of this study was to determine the prevalence of intestinal metaplasia among patients with symptoms suggestive of gastroesophageal reflux disease (GERD) and to study clinical, endoscopic, and histologic associations with intestinal metaplasia at the squamocolumnar junction.
METHODS: One hundred and eighty-six patients with symptoms indicating gastroesophageal reflux were included in the study. A new classification of the Z-line appearance was used.
RESULTS: The Z-line appearance was found to correlate with the prevalence of intestinal metaplasia at the squamocolumnar junction (P = 0.0001). Intestinal metaplasia at the squamocolumnar junction was found in 15.0% of the patients. There was a statistically significant association between intestinal metaplasia at the squamocolumnar junction and tongues of columnar epithelium at the Z-line (P = 0.020), intestinal metaplasia in the cardia (P = 0.020), positive CLO test (P = 0.026), smoking (P = 0.041), and age (P = 0.050). There was no association with endoscopic or histologic signs of esophagitis or with the severity or duration of GERD symptoms.
CONCLUSION: Intestinal metaplasia at the squamocolumnar junction correlates with the Z-line appearance, which would justify a new classification.

Entities:  

Mesh:

Year:  2000        PMID: 10672829     DOI: 10.1080/003655200750024470

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.

Authors:  Panteleimon Kountourakis; Jaffer A Ajani; Marta Davila; Jeffrey H Lee; Manoop S Bhutani; Julie G Izzo
Journal:  Gastrointest Cancer Res       Date:  2012-03

2.  The Z-line appearance and prevalence of intestinal metaplasia among patients without symptoms or endoscopical signs indicating gastroesophageal reflux.

Authors:  B Wallner; A Sylvan; R Stenling; K G Janunger
Journal:  Surg Endosc       Date:  2001-05-02       Impact factor: 4.584

3.  IMportance of an Irregular Z Line: Is Barrett's in the Eye of the Beholder?

Authors:  Swathi Eluri; Nicholas J Shaheen
Journal:  Dig Dis Sci       Date:  2018-06       Impact factor: 3.199

4.  Endoscopic observations around the gastroesophageal junction in patients with symptomatic gastroesophageal reflux disease in South Asia.

Authors:  Navarathne M M Navarathne; Vasitha Abeysuriya; A Ileperuma; U L Thoufeek
Journal:  Indian J Gastroenterol       Date:  2010-10-13

5.  Endoscopically defined gastroesophageal junction coincides with the anatomical gastroesophageal junction.

Authors:  Bengt Wallner
Journal:  Surg Endosc       Date:  2008-12-06       Impact factor: 4.584

6.  The Frequencies of Gastroesophageal and Extragastroesophageal Symptoms in Patients with Mild Erosive Esophagitis, Severe Erosive Esophagitis, and Barrett's Esophagus in Taiwan.

Authors:  Sung-Shuo Kao; Wen-Chih Chen; Ping-I Hsu; Seng-Kee Chuah; Ching-Liang Lu; Kwok-Hung Lai; Feng-Woei Tsai; Chun-Chao Chang; Wei-Chen Tai
Journal:  Gastroenterol Res Pract       Date:  2013-08-12       Impact factor: 2.260

7.  Endoscopic findings around the gastroesophageal junction: an experience from a tertiary hospital in Korea.

Authors:  Ji Hyun Kim; Jin Ki Hwang; Juhyung Kim; Sehe Dong Lee; Beom Jae Lee; Jae Seon Kim; Young-Tae Bak
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

8.  Hill classification is superior to the axial length of a hiatal hernia for assessment of the mechanical anti-reflux barrier at the gastroesophageal junction.

Authors:  Ida Hansdotter; Ove Björ; Anna Andreasson; Lars Agreus; Per Hellström; Anna Forsberg; Nicholas J Talley; Michael Vieth; Bengt Wallner
Journal:  Endosc Int Open       Date:  2016-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.